A comparative study of tissue factor and kaolin on blood coagulation assays using rotational thromboelastometry and thromboelastography.
Rotational thromboelastometry (ROTEM) and thromboelastography (TEG) have been increasingly used to diagnose acute coagulopathy and guide blood transfusion. The tests are routinely performed using different triggering activators such as tissue factor and kaolin, which activate different pathways yielding different results. To optimize the global blood coagulation assays using ROTEM and TEG, we conducted a comparative study on the activation methods employing tissue factor and kaolin at different concentrations as well as standard reagents as recommended by the manufacturer of each device. Key parameter values were obtained at various assay conditions to evaluate and compare coagulation and fibrinolysis profiles of citrated whole blood collected from healthy volunteers. It was found that tissue factor reduced ROTEM clotting time and TEG R, and increased ROTEM clot formation time and TEG K in a concentration-dependent manner. In addition, tissue factor affected ROTEM alpha angle, and maximum clot firmness, especially in the absence of kaolin activation, whereas both ROTEM and TEG clot lysis (LI30, CL30, and LY30) remained unaffected. Moreover, kaolin reduced ROTEM clotting time and TEG R and K, but to a lesser extent than tissue factor, in-tem and ex-tem. Correlations in all corresponding parameters between ROTEM and TEG were observed, when the same activators were used in the assays compared with lesser correlations between standard kaolin TEG and ROTEM (INTEM/EXTEM). The two types of viscoelastic point-of-care devices provide different results, depending on the triggering reagent used to perform the assay. Optimal assay condition was obtained to reduce assay time and improve assay accuracy.
aDefence Research and Development Canada, Toronto Research Centre bSt Michael's Hospital, Toronto, Ontario, Canada.
Henry T
HT
Peng
Richard
R
Grodecki
Sandro
S
Rizoli
Pang N
PN
Shek
D001778:Blood Coagulation Disorders / Q000175:diagnosis; D001780:Blood Coagulation Tests / Q000379:methods*; D005260:Female; D006801:Humans; D007616:Kaolin / Q000009:adverse effects*; D008297:Male; D013916:Thrombelastography / Q000379:methods*; D013925:Thromboplastin / Q000032:analysis
D007616:Kaolin; D013925:Thromboplastin